164 related articles for article (PubMed ID: 14713894)
1. Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro.
Tabel G; Hoa NT; Tarnawski A; Chen J; Domek M; Ma TY
J Lab Clin Med; 2003 Dec; 142(6):421-30. PubMed ID: 14713894
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori vacuolating cytotoxin (VacA) alters cytoskeleton-associated proteins and interferes with re-epithelialization of wounded gastric epithelial monolayers.
Pai R; Sasaki E; Tarnawski AS
Cell Biol Int; 2000; 24(5):291-301. PubMed ID: 10805963
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori vacuolating cytotoxin inhibits duodenal bicarbonate secretion by a histamine-dependent mechanism in mice.
Tuo B; Song P; Wen G; Sewald X; Gebert-Vogl B; Haas R; Manns M; Seidler U
J Infect Dis; 2009 Feb; 199(4):505-12. PubMed ID: 19099486
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo.
de Paulis A; Prevete N; Rossi FW; Rivellese F; Salerno F; Delfino G; Liccardo B; Avilla E; Montuori N; Mascolo M; Staibano S; Melillo RM; D'Argenio G; Ricci V; Romano M; Marone G
J Immunol; 2009 Sep; 183(6):3761-9. PubMed ID: 19692643
[TBL] [Abstract][Full Text] [Related]
6. Duodenal and gastric cell regenerating epithelia on margins of human duodenal ulcer and presence of H. pylori--an electron microscopic study.
Ogata T
Histol Histopathol; 1997 Jan; 12(1):57-68. PubMed ID: 9046044
[TBL] [Abstract][Full Text] [Related]
7. Vacuolating cytotoxin A is associated with increased thrombin generation in gastric mucosa.
Suzuki Y; Gabazza EC; Imoto I; James RF; Hirayama T; Wada A; Horiki N; Nakamura M; Inoue H; Kuroda M; Ogura A; Taguchi Y; Yano Y; Taguchi O; Suzuki K; Adachi Y
Helicobacter; 2005 Aug; 10(4):323-31. PubMed ID: 16104949
[TBL] [Abstract][Full Text] [Related]
8. Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: role of cytokines and gastrin-somatostatin link.
Brzozowski T; Konturek PC; Konturek SJ; Kwiecien S; Pajdo R; Karczewska E; Stachura J; Hahn EG
Digestion; 1999; 60(1):22-33. PubMed ID: 9892795
[TBL] [Abstract][Full Text] [Related]
9. [Recurring duodenal ulcer. Evaluation of previous complications as a predictive factor of ulcer recurrence after eradication of Helicobacter pylori].
Pellicano R; Palmas F; Gardino L; Greco S; Perardi S; Sanseverino P; Pugliese G; Palmas C; Pellicano D; Rizzetto M; Verme G; Ponzetto A
Minerva Gastroenterol Dietol; 1997 Sep; 43(3):111-6. PubMed ID: 16501478
[TBL] [Abstract][Full Text] [Related]
10. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Multiple Center Study Group In Beijing Area, China
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976
[TBL] [Abstract][Full Text] [Related]
11. Characterization of wound reepithelialization using a new human tissue-engineered corneal wound healing model.
Carrier P; Deschambeault A; Talbot M; Giasson CJ; Auger FA; Guérin SL; Germain L
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1376-85. PubMed ID: 18385053
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori toxin inhibits growth and proliferation of cultured gastric cells-Kato III.
Chang K; Fujiwara Y; Wyle F; Tarnawski A
J Physiol Pharmacol; 1993 Mar; 44(1):17-22. PubMed ID: 8518421
[TBL] [Abstract][Full Text] [Related]
14. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of antral CD4 T and CD19 B cells in patients with Helicobacter pylori-related peptic ulcer disease.
Goll R; Husebekk A; Isaksen V; Kauric G; Hansen T; Florholmen J
Scand J Immunol; 2005 Jan; 61(1):92-7. PubMed ID: 15644128
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori culture supernatant inhibits binding and proliferative response of human gastric cells to epidermal growth factor: implications for H.pylori interference with ulcer healing?
Fujiwara Y; Wyle F; Arakawa T; Domek MJ; Fukuda T; Kobayashi K; Tarnawski A
Digestion; 1997; 58(3):299-303. PubMed ID: 9243127
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein.
Targosz A; Pierzchalski P; Krawiec A; Szczyrk U; Brzozowski T; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Jun; 57(2):265-78. PubMed ID: 16845230
[TBL] [Abstract][Full Text] [Related]
18. Controversies in the Helicobacter pylori/duodenal ulcer story.
Hobsley M; Tovey FI; Holton J
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1171-5. PubMed ID: 18589464
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF164) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-beta release from epithelial cells.
Bulut K; Pennartz C; Felderbauer P; Ansorge N; Banasch M; Schmitz F; Schmidt WE; Hoffmann P
Scand J Gastroenterol; 2006 Jun; 41(6):687-92. PubMed ID: 16716967
[TBL] [Abstract][Full Text] [Related]
20. [Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof].
Xie Y; Zhu J; Zhou XJ; Chen J; Lu NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2683-9. PubMed ID: 17199977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
